Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,338Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3KNIGHT THERAPEUTICS INC.

02 2MYLAN PHARMACEUTICALS ULC

03 3PHARMASCIENCE INC

04 2SANDOZ CANADA INCORPORATED

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RIVASTIGMINE

Brand Name : EXELON PATCH 15

Dosage Form : PATCH

Dosage Strength : 13.3MG/24HOUR

Packaging : 30

Approval Date :

Application Number : 2432803

Regulatory Info : Prescription

Registration Country : Canada

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RIVASTIGMINE

Brand Name : EXELON PATCH 5

Dosage Form : PATCH

Dosage Strength : 4.6MG/24HOUR

Packaging : 30

Approval Date :

Application Number : 2302845

Regulatory Info : Prescription

Registration Country : Canada

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RIVASTIGMINE

Brand Name : EXELON PATCH 10

Dosage Form : PATCH

Dosage Strength : 9.5MG/24HOUR

Packaging : 30

Approval Date :

Application Number : 2302853

Regulatory Info : Prescription

Registration Country : Canada

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RIVASTIGMINE

Brand Name : RIVASTIGMINE PATCH 5

Dosage Form : PATCH

Dosage Strength : 4.6MG/24HOUR

Packaging :

Approval Date :

Application Number : 2479540

Regulatory Info : Prescription

Registration Country : Canada

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RIVASTIGMINE

Brand Name : RIVASTIGMINE PATCH 10

Dosage Form : PATCH

Dosage Strength : 9.5MG/24HOUR

Packaging :

Approval Date :

Application Number : 2479559

Regulatory Info : Prescription

Registration Country : Canada

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RIVASTIGMINE

Brand Name : RIVASTIGMINE PATCH 15

Dosage Form : PATCH

Dosage Strength : 13.3MG/24HOUR

Packaging :

Approval Date :

Application Number : 2479567

Regulatory Info : Prescription

Registration Country : Canada

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RIVASTIGMINE

Brand Name : SANDOZ RIVASTIGMINE PATCH 10

Dosage Form : PATCH

Dosage Strength : 9.5MG/24HOUR

Packaging : 30

Approval Date :

Application Number : 2426307

Regulatory Info : Prescription

Registration Country : Canada

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RIVASTIGMINE

Brand Name : SANDOZ RIVASTIGMINE PATCH 5

Dosage Form : PATCH

Dosage Strength : 4.6MG/24HOUR

Packaging : 30

Approval Date :

Application Number : 2426293

Regulatory Info : Prescription

Registration Country : Canada

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RIVASTIGMINE

Brand Name : MYLAN-RIVASTIGMINE PATCH 5

Dosage Form : PATCH

Dosage Strength : 4.6MG/24HOUR

Packaging : 30

Approval Date :

Application Number : 2423413

Regulatory Info : Prescription

Registration Country : Canada

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

RIVASTIGMINE

Brand Name : MYLAN-RIVASTIGMINE PATCH 10

Dosage Form : PATCH

Dosage Strength : 9.5MG/24HOUR

Packaging : 30

Approval Date :

Application Number : 2423421

Regulatory Info : Prescription

Registration Country : Canada

blank